2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014

DateTitle
03-Dec-2012Covance Receives SFDA GLP Certification for Its Early Development Facility in Shanghai, China Print
03-Dec-2012Covance Earns CEO Cancer Gold Standard Employer Accreditation Print
05-Nov-2012Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million Print
16-Oct-2012Covance and NAFC Sponsor Free Medical Clinic for More Than 1,200 Patients in Dallas, Texas Print
25-Jul-2012Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million Print
18-Jun-2012Covance Appoints Dr. Steve Street to Lead Worldwide Safety Assessment and Pharmaceutical Chemistry Services Print
13-Jun-2012Covance U.K. Sites Receive Carbon Trust Standard Accreditation Print
02-May-2012Covance Announces Executive Appointments Print
02-May-2012Covance Reports First Quarter Net Revenue Growth Of 5.7% To $531M, EPS Of $0.60, And Adjusted Net Orders Of $704M Print
26-Apr-2012Covance-BML to Expand Clinical Trial Laboratory in Japan Print
02-Feb-2012Covance and BioPontis Alliance Collaborate to Bridge Drug Development Gap Print
25-Jan-2012Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M Print
25-Jan-2012Covance Board Authorizes $300 Million Stock Buyback Print
12-Jan-2012Covance, Inserm Transfert SA, and Inserm Transfert Initiative Enter Four-Year Scientific Agreement Print
10-Jan-2012Covance Microbiology Laboratory Receives ISO Accreditation Print